• pic 1

    A medical device holding company

  • pic 2

    Development and acquisition of medical device businesses

  • pic 3

    Get in touch, send us an email

We specialise in interventional cardiology, radiology, peripheral vascular and non-vascular markets

About us

Q3 Medical Devices Limited

Q3 Medical Devices Limited is an Irish based holding company with multiple operations in Germany. The holding and its companies are focused on the development, manufacturing, and distribution of minimally invasive devices for the treatment of patients with cardiology, peripheral vascular and non-vascular diseases.

Q3 Medical Devices Limited was formed by a global group of entrepreneurs, manufactures, distributors, industry doctors, and investors focused on the development and acquisition of medical device businesses with annual revenues between 1 -10 Million. The acquisitions are targeted in areas that expand the groups manufacturing base and capabilities, growth of its distribution channels, and accelerating its products offering focused on the minimally invasive treatment of patients with cardiology, peripheral vascular and non-vascular diseases.

Business Concept

Opportunity to expand

In a market where there has been considerable effort to increase the size and scope of the offerings across multiple specialties and where there has been significant consolidation at the Large Cap and Mid Cap Level Q3 Medical believes there is a significant opportunity to expand its competitive base through the organic growth of its existing businesses and through acquisitions.

Our vision

Q3 Medical is focused on opportunities that will accelerate the expansion of its core manufacturing base as well as enhanced capabilities for innovative developments, distribution channel expansion, and accelerated product offering for patients with cardiology, peripheral vascular and non-vascular diseases.

Strategy

Q3 Medical believes that the global market is dependent on 3 main drivers for strategic success:
1. Developing innovative solutions that can drive cost from the healthcare system while increasing capacity while providing a high quality product at a reasonable price.
2. Relationship with the triangle if influence (Finance, Care Givers, and Patients) play an ever increasing role in success.
3. Consolidation creates opportunities for the company’s core business expansion in production, development, and distribution.

Q3 Medical plans to leverage its capabilities in innovation, channel management, and acquisition to insure its long term success.

Opportunity

Competitive Opportunity

Q3 Medical believes it has a competitive advantage through its owned companies through the:
1. Introduction of a wide ranging technology platform with enhanced capabilities across the large clinical market in the 20 Billion + market for interventional Cardiology, Radiology/Peripheral Vascular, and Non Vascular products.
2. Versatility and innovation in its manufacturing base to develop technology that can reduce cost of care.
3. Leveraging of its global relationships and those of its current and future channel partners who have been left with limited product choice opportunities due channel consolidations resulting from large cap and mid cap channel acquisitions.

Growth Targets

The company expects to see organic grow through the introduction of new technology offering of its owned companies and through acquisitions that will accelerate its growth focused on expanding its core manufacturing base as well as enhanced capabilities for innovative developments, distribution channel expansion, and accelerated product offering for the minimally invasive treatment of patients with cardiology, peripheral vascular, and non-vascular diseases.

Organization

Q3 Medical Devices Limited is a holding business organized to assist its companies in the management and facilitation of:
1. Capital needs and risk
2. Improved efficiencies
3. Accelerated growth

Q3 Medicals organization is organized to react rapidly to market changes made, facilitated, and implemented at the business level while matters of acquisition strategy, areas of future focus, and strategic direction are made at the Q3 board level. Each business is independently responsible for its operations including but not limited to product development, production, and distribution.

Areas

Interventional Cardiology

  • Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery.

    Additionally, interventional cardiology procedure of primary angioplasty is now the gold standard of care for an acute myocardial infarction. It involves the extraction of clots from occluded coronary arteries and deployment of stents and balloons through a small hole made in a major artery, which has given it the name "pin-hole surgery" (as opposed to "key-hole surgery").

Intervention Radiology / Peripheral Vascular

  • Interventional radiology is a medical sub-specialty of radiology which utilizes minimally-invasive image-guided procedures to diagnose and treat diseases in nearly every organ system. The concept behind interventional radiology is to diagnose and treat patients using the least invasive techniques currently available in order to minimize risk to the patient and improve health outcomes.

    As the inventors of angioplasty and the catheter-delivered stent, interventional radiologists pioneered modern minimally-invasive medicine. Using X-rays, CT, ultrasound, MRI, and other imaging modalities, interventional radiologists obtain images which are then used to direct interventional instruments throughout the body. These procedures are usually performed using needles and narrow tubes called catheters, rather than by making large incisions into the body as in traditional surgery.

Interventional Non Vascular

  • Non-vascular interventions are minimally invasive interventional radiology procedures that do not involve blood vessels. The physician uses imaging technology to guide instruments inside the body without open surgery.

    Interventional radiologists often use ultrasound and CT scans to guide catheter (tube) placement to drain abscesses and other fluid collections. Imaging technology is also used for biopsies of deep tumors in the chest, abdomen and pelvis.

Meet the group

Eric K Mangiardi
C.E.O.

Prior to this role, Mangiardi held Board positions and or was an investor in QualiMed , AMG, and Alveolus where he served as the CEO and founder before the company was acquired by Merit Medical and now forms that foundation of their Merit Endotek Division. He has 20 years of experience and a number of patents and patent applications in his name for various novel medical devices. Mangiardi holds an MSc in International Marketing, from the University of Strathclyde, Glasgow, Scotland and a Bachelors of Science in Finance and Marketing from the University of Dayton, USA.


Manfred Gülcher
Chief Risk Officer

Prior to this role, Gülcher was Founder and Co-Managing Director at QualiMed where he held numerous position as the Head of Regulatory, Quality, Drug Device Combination Technologies, and oversaw the legal functions within the business. Gülcher is a graduate in Electronic Engineering and previously worked as manager for quality and regulatory affairs at Devon Medical GmbH, Hamburg, and as Head of medical devices approval at DEKRA GmbH.

Group of companies


qualimed

As a leader in the development of innovative medical device technology to a large variety of interventional and surgical specialties doctors and the patients they treat globally, QualiMed is continually focused on enhancing its team of medical device professionals who are interested in working in the fast paced ever changing environment of medical device development.

Qualimed Innovative Medizinprodukte GmbH
Boschstrasse 16, 21423, Winsen, Germany

Phone +49 4171 6578 0
Fax +49 4171 6578 11
info@qualimed.de
www.qualimed.de

qualimed

amg International develops, manufactures and sells stents, stent implantation systems and balloon catheters, which are used primarily in interventional cardiology. That is why we call ourselves – Das Stent Company. amg International aims to provide the cardiologist with a continuous flow of innovative new products.

amg International GmbH
Schulstraße 8, Raesfeld-Erle, 46348, Germany

Phone +49 2865 9577 0
Fax +49 2865 9577 11
info@thestentcompany.com
www.thestentcompany.com

altea world map

Contact us

Security

Address:
Q3 Medical Devices Limited
88 Harcourt Street
Dublin 2, Ireland

 +49 172 243 9649
 info@q3medical.com

DISCLAIMER Copyright © 2013. Q3 Medical Devices Limited.
Powered by Pre Inception